Reproducibility of common semi-quantitative parameters for evaluating lung cancer glucose metabolism with positron emission tomography using 2-deoxy-2-[18F]fluoro-D-glucose.
about
A review on segmentation of positron emission tomography imagesReproducibility of (18)F-fluoromisonidazole intratumour distribution in non-small cell lung cancerPET/CT Assessment of Response to Therapy: Tumor Change Measurement, Truth Data, and Error.Methodological considerations in quantification of oncological FDG PET studies.Cancer Response Criteria and Bone Metastases: RECIST 1.1, MDA and PERCIST.Reproducibility of 18F-FDG microPET studies in mouse tumor xenografts.The role of (18)F-FDG PET in the differentiation between lung metastases and synchronous second primary lung tumours.Role of PET quantitation in the monitoring of cancer response to treatment: Review of approaches and human clinical trials.Positron emission tomography-computed tomography standardized uptake values in clinical practice and assessing response to therapyQuantitative imaging biomarkers: a review of statistical methods for computer algorithm comparisons.Positron Emission Tomography (PET) in OncologyFrom RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.FDG-PET Response Prediction in Pediatric Hodgkin's Lymphoma: Impact of Metabolically Defined Tumor Volumes and Individualized SUV Measurements on the Positive Predictive Value.Design considerations for using PET as a response measure in single site and multicenter clinical trials.Comparing 18F-Fluorodeoxyglucose Positron Emission Tomography and Video-assisted Thoracoscopic Surgery in the Evaluation of Small Pulmonary Nodules in Patients with a History of MalignancyQuantifying and reducing the effect of calibration error on variability of PET/CT standardized uptake value measurements.Noise considerations for PET quantification using maximum and peak standardized uptake value.How to study optimal timing of PET/CT for monitoring of cancer treatmentVariance of SUVs for FDG-PET/CT is greater in clinical practice than under ideal study settingsTwo-time-point FDG PET/CT: liver SULmean repeatability.Alpha-v integrins as therapeutic targets in oncology.Posttreatment FDG-PET uptake in the supraglottic and glottic larynx correlates with decreased quality of life after chemoradiotherapy.Inter-observer agreement improves with PERCIST 1.0 as opposed to qualitative evaluation in non-small cell lung cancer patients evaluated with F-18-FDG PET/CT early in the course of chemo-radiotherapy.Quantitative FDG PET/CT in the community: experience from interpretation of outside oncologic PET/CT exams in referred cancer patientsA Virtual Clinical Trial of FDG-PET Imaging of Breast Cancer: Effect of Variability on Response Assessment.Strategies of assessing and quantifying radiation treatment metabolic tumor response using F18 FDG Positron Emission Tomography (PET).PET/CT in therapy evaluation of patients with lung cancer.Repeatability of SUV in Oncologic 18F-FDG PET.Comparative study with new accuracy metrics for target volume contouring in PET image guided radiation therapy.Impact of the definition of peak standardized uptake value on quantification of treatment response.A partial volume effect correction tailored for 18F-FDG-PET oncological studies.Effects of blood glucose level on 18F fluorodeoxyglucose (18F-FDG) uptake for PET/CT in normal organs: an analysis on 5623 patients.
P2860
Q26825470-CA672323-A5C1-443C-84CC-7E8C426C19F4Q28821970-36638E40-7906-4667-B509-5ECABE12F889Q33517102-099D72C5-0CE6-4B1F-B33E-03794A983C78Q33915164-B8353A9F-889F-43AA-AD23-CA821512CD54Q34023973-F160344A-1F5B-4FB4-8BA6-3CA18F1AC9EEQ34164724-9E5B5FC4-ED76-43CB-9D38-C07FEE0A15E8Q34166842-FA91FEE5-78D5-469B-BC57-C599A5A34C29Q34175770-9CBB9F3B-02DC-43A2-9BEF-B0A6908B1FABQ34517660-20CBA55A-1EA7-419D-B88C-4947F907F4B2Q34681714-A5EFB4A4-6932-46A3-BE02-B8E487FB50C7Q34774840-91C3ED7A-1928-4270-B22F-7603BDE80B5DQ34978457-9D6F3B68-6F73-4D1E-B32F-38593D531531Q35237507-4565250B-3AA2-4939-A768-5610D36C069AQ35653277-D9E9ECBC-FF96-45AD-90E9-2771F897B8CDQ35769878-B8D8D151-E77D-4A07-991D-74FA980C141EQ35816701-E4A7E310-6B04-48C9-B677-00BCC175B0F8Q36158583-C6477C8D-B52F-4F3C-B2B1-F5B892AF54C2Q36337232-02C53AC1-8215-40C4-9F65-5E9160A07F44Q36626050-FF10EA5F-AA93-4882-B994-23377E2D48E5Q36910835-8B61ECED-17F5-4A7F-9014-618A1833B78CQ37008623-1B349975-4B79-459E-95D5-B230FA9653D7Q37235767-958E0873-5DBB-40AC-8789-FC2510360DA0Q37273224-384972F3-9210-41F7-9967-D82E6D5ACC90Q37684583-30936079-7DB1-45A5-BDF3-44D951E4300CQ37721526-950E639B-C4CB-4B65-97F0-B617564944CAQ37787276-3F30ADB8-BF62-4E01-9299-C66626D533FEQ38202189-26E58206-9599-4FF9-9B9F-55E5613AAB3BQ38945159-C067BE98-A743-45AB-8AA1-15E186E596ABQ41513145-6325082E-44B3-46DC-A503-FCA355673312Q42092531-8471862F-29C0-4ED8-9367-4EEE6986443EQ42255415-A40CF59D-7536-46DA-B191-B784EE8F4975Q47825180-FD02484B-17E6-40B7-87C4-738B59470BB2
P2860
Reproducibility of common semi-quantitative parameters for evaluating lung cancer glucose metabolism with positron emission tomography using 2-deoxy-2-[18F]fluoro-D-glucose.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Reproducibility of common semi ...... deoxy-2-[18F]fluoro-D-glucose.
@en
Reproducibility of common semi ...... deoxy-2-[18F]fluoro-D-glucose.
@nl
type
label
Reproducibility of common semi ...... deoxy-2-[18F]fluoro-D-glucose.
@en
Reproducibility of common semi ...... deoxy-2-[18F]fluoro-D-glucose.
@nl
prefLabel
Reproducibility of common semi ...... deoxy-2-[18F]fluoro-D-glucose.
@en
Reproducibility of common semi ...... deoxy-2-[18F]fluoro-D-glucose.
@nl
P2093
P1476
Reproducibility of common semi ...... -deoxy-2-[18F]fluoro-D-glucose
@en
P2093
Kenneth R Zasadny
Richard L Wahl
Yuji Nakamoto
P304
P356
10.1016/S1536-1632(01)00004-X
P50
P577
2002-03-01T00:00:00Z